ClinVar Miner

Submissions for variant NM_004004.6(GJB2):c.-6T>A (rs148136545)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000037809 SCV000061471 benign not specified 2012-05-15 criteria provided, single submitter clinical testing -6T>A in Exon 02 of GJB2: This variant is not expected to have clinical signific ance because it has been identified in 1.5% (55/3738) of African American chromo somes from a broad population by the NHLBI Exome Sequencing Project (http://evs. gs.washington.edu/EVS; dbSNP rs148136545) and has been reported as benign based on an equal occurance in cases and controls (Tang 2006, Al-Qahtani, 2010, Shan 2 010).
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000037809 SCV000331239 benign not specified 2016-05-31 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000296493 SCV000383051 likely benign Mutilating keratoderma 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000351365 SCV000383052 likely benign Hystrix-like ichthyosis with deafness 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000391696 SCV000383053 likely benign Keratitis ichthyosis and deafness syndrome 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000311687 SCV000383054 likely benign Nonsyndromic Hearing Loss, Recessive 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000336963 SCV000383055 likely benign Nonsyndromic Hearing Loss, Dominant 2016-06-14 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000037809 SCV000698271 benign not specified 2019-01-08 criteria provided, single submitter clinical testing Variant summary: GJB2 c.-6T>A is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 0.0012 in 275934 control chromosomes, predominantly at a frequency of 0.012 within the African subpopulation in the gnomAD database, including 3 homozygotes. The observed variant frequency within African control individuals in the gnomAD database is approximately 36-fold of the estimated maximal expected allele frequency for a pathogenic variant in GJB2 causing Non-Syndromic Hearing Loss phenotype (0.00034), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African origin. The variant, c.-6T>A, has been reported in the literature in individuals affected with Non-Syndromic Hearing Loss, but also in controls (Gasmelseed_2004, Tang_2006, Shan_2010, Bosch_2014) and is considered by multiple authors a non-pathogenic common variant. These report(s) do not provide unequivocal conclusions about association of the variant with Non-Syndromic Hearing Loss. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submissions from other clinical diagnostic laboratories (evaluation after 2014) cite the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000586780 SCV000885511 benign not provided 2017-08-30 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000586780 SCV001143675 benign not provided 2019-02-11 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.